Metabolic dysfunction-associated fatty liver disease and hepatocellular carcinoma: present and future

Hepatobiliary Surg Nutr. 2023 Dec 1;12(6):945-948. doi: 10.21037/hbsn-23-539. Epub 2023 Nov 15.
No abstract available

Keywords: Metabolic dysfunction-associated fatty liver disease (MAFLD); epidemiology; hepatocellular carcinoma (HCC); metabolic dysfunction-associated steatotic liver disease; nonalcoholic fatty liver disease.

Publication types

  • Editorial
  • Comment